Bacterial biofilms

Pediatric Asthma, Allergy and Immunology

Volumn 20, Issue 3, 2007, Pages 191-195

  Mehrotra, Anjuli ^a  

^a Northwest Asthma & Allergy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; EXOPOLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; BIOPSY; CAUSAL ATTRIBUTION; ENDOSCOPIC SURGERY; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PLANKTON; PRIORITY JOURNAL; RHINOSINUSITIS; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS;

EID: 36448995849     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2007.010     Document Type: Article

References (34)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999; 248:1318-1322.
2. Potera C. Forging a link between biofilms and disease. Science 1999; 283:1837-1839.
3. Costerton JW, et al. Microbial biofilms. Ann Rev Microbiol 1995; 49:711-745.
4. Archibald LK, Gaynes RP. Hospital acquired infections in the United States: The importance of interhospital comparisons. Nosocomial Infect 1997; 11:245-255.
5. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Ann Rev Microbiol 2002; 56:187-209.
6. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Ann Rev Microbiol 2000; 54:49-79.
7. Branda SS, Vik S, Friedman L, Kolter R. Biofilms: The matrix revisited. Trends Microbiol 2005; 13:20-26.
8. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope. 2005; 115:578-582.
9. De Beer D, Stoodley P, Roe F, et al. Effects of biofilm structure on oxygen distribution and mass transport. Biotechnol Bioeng. 1994; 43:1131-1138.
10. Stewart P, Costerton J. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358(9276):135-138.
11. Monzon M, et al. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 2002; 44:319-324.
12. Palmer JN. Bacterial biofilms: Do they play a role in chronic sinusitis? Otolaryngol Clin N Am 2005; 38:1193-1201.
13. Patel R. Biofilms and antimicrobial resistance. Clin Orthopaed Related Res 2005; 437:41-47.
14. Mah TC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9(1):34-39.
15. Suci PA, Mittelman MW, Yu FP, Geesey GG. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 1994; 38(9):2125-2133.
16. Dunne WM, et al. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993; 37:2522-2526.
17. Evans DJ, et al. Susceptibility of P. aeruginosa and E. coli biofilms towards ciprofloxacin: Effect of specific growth rate. J Antimicrob Chemother 1991; 27:177-184.
18. Duguid IG, et al. Growth-rate independent killing by ciprofloxacin of biofilm-derived Staphyloccocus epidermidis; Evidence for cell-cycle dependency. J Antimicrob Chemother 1992; 30:791-802.
19. Desai M, et al. Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrob Chemother 1998; 42:153-160.
20. Brown MR, Barker J. Unexplored reservoirs of pathogenic bacteria: protozoa and biofilms. Trends Microbiol. 1999; 7:46-50.
21. Hengge-Aronis R. Regulation of gene expression during entry into stationary phase. In: Neidhart FC, et al., eds. Escherichia coli and Salmonella: Cellular and molecular biology. ASM Press, pp. 1497-1512.
22. Foley I, et al. General stress response master regulator rpoS is expressed in human infection: A possible role in chronicity. J Antimicrob Chemother 1999; 43:163-165.
23. Cochran WL, et al. Role of RpoS and AlgT in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide and monochloramine. J Appl Microbiol 2000; 88:546-553.
24. Xu KD, et al. Biofilm resistance to antimicrobial agents. Microbiology 2000; 146:547-549.
25. Cryer J, et al. Evidence of bacterial biofilms in human chronic sinusitis. ORL 2004; 66:155-158.
26. Sanclement JA, et al. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005; 115:578-582.
27. Perloff JR, Palmer JN. Evidence of bacterial biofilms in a rabbit model of sinusitis. Am J Rhinol 2005; 19(1):1-6.
28. Perloff JR, et al. Evidence of bacterial biofilms on frontal recess stents in patients with chronic rhinosinusitis. Am J Rhinol 2004; 18(6):377-380.
29. Sanderson AR, et al. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006; 116:1121-1126.
30. Hazan Z, et al. Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves. Antimicrob Agents and Chemother 2006; 50(12):4144-4152.
31. Gagnon RF, et al. Time-kill efficacy of antibiotics in combination with rifampin against Staph epidermidis biofilms. Adv Perit Dial 1994; 10:189-192.
32. Ghani M, et al. Ceftazidime, gentamicin, and rifampin in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Can J Microbiol 1997; 43:999-1004.
33. Nalca Y, et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: A global approach. Antimicrob Agents Chemother 2006 May;50(5):1680-1688.
34. Yasuda H, et al. Interaction between clarithromycin and biofilms formed by Staphyococcus epidermidis. Antimicrob Agents Chemother 1997; 38:138-141.